Louisiana could become the first state in the country to categorize mifepristone and misoprostol — the drugs used to induce an abortion — as controlled dangerous substances, threatening incarceration and fines if an individual possesses the pills without a valid prescription or outside of professional practice.

Legislators in Baton Rouge added the provision as a last-minute amendment to a Senate bill that would criminalize an abortion if someone gives a pregnant woman the pills without her consent, a scenario of “coerced criminal abortion” that nearly occurred with one senator’s sister.

A pregnant woman obtaining the two drugs “for her own consumption” would not be at risk of prosecution. But, with the exception of a health-care practitioner, a person helping her get the pills would be.

Louisiana already bans both medication and surgical abortions except to save a patient’s life or because a pregnancy is “medically futile.” Lawmakers just rejected adding exceptions for teenagers under 17 who become pregnant through rape or incest.

The amendment would list mifepristone and misoprostol under the state’s Uniform Controlled Dangerous Substances Act, which regulates depressants, opioids and other sometimes highly addictive drugs. It elicited a strong reaction from more than 240 Louisiana doctors, who called it “not scientifically based.”

“Adding a safe, medically indicated drug for miscarriage management … creates the false perception that these are dangerous drugs that require additional regulation,” they wrote in a letter sent last week to the bill’s sponsor, Republican Sen. Thomas Pressly. They noted misoprostol’s other critical uses, including to prevent gastrointestinal ulcers and to aid in labor and delivery.

“Given its historically poor maternal health outcomes, Louisiana should prioritize safe and evidence-based care for pregnant women,” they urged.

The amendment, written with guidance from Louisiana Right to Life, was added after the Senate unanimously passed S.B. 276 in mid-April. The measure is awaiting a final vote in the House before the session ends June 3, with little opposition expected.

“As Senator Pressly has stated, the medical community regularly uses controlled substances in a myriad of medical situations, including emergencies,” said Sarah Zagorski, communications director for the antiabortion organization. “The use of these drugs for legitimate health care needs will still be available, just like all other controlled substances are still available for legitimate uses.”